Effect of somatostatin on rabbit isolated coronary arteries

Japanese Journal of Pharmacology

Volumn 90, Issue 1, 2002, Pages 51-58

  Ruiz, Emilio ^a   Padilla, Eugenia ^a   Tejerina, Teresa ^a  

^a SCHOOL OF MEDICINE   (Spain)

Author keywords

5 Hydroxytryptamine; Acetylcholine; Coronary artery; Nitric oxide; Somatostatin

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ACETYLCHOLINE; INDOMETACIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PROSTAGLANDIN SYNTHASE INHIBITOR; SEROTONIN; SOMATOSTATIN; SOMATOSTATIN DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY DILATATION; ARTICLE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; DRUG RESPONSE; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; IN VITRO STUDY; ISOLATED ARTERY; MALE; NONHUMAN; QUALITATIVE ANALYSIS; RABBIT; REGULATORY MECHANISM; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

EID: 0036747047     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.90.51     Document Type: Article

References (35)

1. Lamping K, Piegors D, Benzuly K, Armstrong M and Heistad D: Enhanced coronary vasoconstrictive response to serotonin subsides after removal of dietary cholesterol in atherosclerotic monkeys. Arterioscler Thromb 14, 951 - 957 (1994)
2. Fonseca F, Izar M, Fuster V, Gallo R, Paurean A, Fallon J, Schacter EN, Chesebro J and Badimon JJ: Chronic endothelial dysfunction after oversized coronary balloon angioplasty in pigs: a 12-weeks follow-up of coronary vasoreactivity in vivo and in vitro. Atherosclerosis 154, 61 - 69 (2001)
3. Kugiyama K, Ohgushi M, Motoyama T, Sugiyama S, Soejima H, Matsumura T, Yoshimura M, Ogawa H and Yasue H: Enhancement of constrictor response of spastic coronary arteries to acetylcholine but not to phenylephrine in patients with coronary spastic angina. J Cardiovasc Pharmacol 33, 414 - 419 (1999)
4. Thorin E: Influence of nitric oxide synthase inhibition and endothelin-1 receptor blockade on acetylcholine-induced coronary artery contraction in vitro in dilated and ischemic cardiomyopathies. J Cardiovasc Pharmacol 38, 90 - 98 (2001)
5. Lam J, Chesebro J, Steele P, Badimon L and Fuster V: Is vasospasm related to platelet deposition? Relationship in an porcine preparation of arterial injury in vivo. Circulation 75, 243 - 248 (1987)
6. 2. J Am Coll Cardiol 37, 308 - 315 (2001)
7. Schmitz J, Apprill PG, Buja L, Willerson J and Campbell W: Vascular prostaglandin and thromboxane production in a canine model of myocardial ischemia. Circ Res 57, 223 - 231 (1985)
8. Brazeau P, Vale W, Burgus R, Ling N, Butcher M, Rivier J. and Gullemin R: Hypothalamic polypeptide that inhibit the secretion of immunoreactive pituitary growth hormone. Science 179, 77 - 79 (1973)
9. Wiest R, Tsai MH and Groszmann RJ: Octreotide potentiates PKC-dependent vasoconstrictors in portal-hypertensive and control rats. Gastroenterology 120, 975 - 983 (2001)
10. Dezsi L, Szentivanyi M Jr, Dornyei G, Lowenstein L, Farago M, Tulassay T and Monos E: Regional differences in nitric oxide dependent vascular responses to somatostatin. Physiol Res 45, 291 - 296 (1996)
11. Dezsi L, Dornyei G, Szentivanyi M Jr, Tulassay T and Monos E: Somatostatin induces vasodilatation in the cat mesenteric artery via endothelium-derived nitric oxide and prostaglandins. Pflugers Arch 433, 536 - 538 (1997)
12. Ruiz E, Del Rio M and Tejerina T: Effects of Somatostatin on resistence and on capacitance rabbit isolated arteries. Eur J Pharmacol 388, 255 - 261 (2000)
13. Medina J and Wolf A: Strategies to antagonise the cyclosporine A-induced proliferation of human pulmonary artery smooth muscle cells: anti-endothelin-1 antibodies, verapamil, and octreotide. Biochem Pharmacol 59, 1459 - 1466 (2000)
14. Lawnicka H, Stepien H, Wyczolkowska J, Kolago B, Kunert-Radek J and Komorowski J: Effect of somatostatin and octreotide on proliferation and vascular endothelial growth factor secretion from murine endothelial cell line (HECa10) culture. Biochem Biophys Res Commun 268, 567 - 571 (2000)
15. Marion-Audibert AM, Nejjari M, Pourreyron C, Anderson W, Gouysse G, Jacquier MF, Dumortier J and Scoazec JY: Effect of endocrine peptides on proliferation, migration and differentiation of human endothelial cells. Gastroenterol Clin Biol 24, 644 - 648 (2000)
16. 2+ movements in the isolated rabbit aorta. Eur J Pharmacol 148, 239 - 244 (1988)
17. Ruiz E and Tejerina T: Relaxant effects of L-citrulline in rabbit vascular smooth muscle. Br J Pharmacol 125, 186 - 193 (1998)
18. Mulvany M and Warshaw D: The active tension-length of vascular smooth muscle related to its cellular components. J Gen Physiol 74, 85 - 104 (1977)
19. Yildiz O, Smith JR and Purdy RE: Serotonin and vasoconstrictor synergism. Life Sci 62, 1723-1732 (1998)
20. Hirata Y, Umemura K, Uametsu T and Nakashima M: An experimental myocardial infarction model in the rat and its properties. Jpn J Pharmacol 67, 51-57 (1995)
21. Kemp BK and Cocks TM: Effects of U46619 on contractions to 5-HT, sumatriptan and methysergide in canine coronary artery and saphenous vein in vitro. Br J Pharmacol 116, 2183-2190 (1995)
22. 2 and 5-hydroxytriptamine receptors subtypes in human coronary arteries. Circulation 87, 874-880 (1993)
23. He G, Yang C and Starr A: Overview of the nature of vasoconstriction in arterial grafts for coronary operations. Ann Thorac Surg 59, 676-683 (1995)
24. Parent R, Hamdad N, Ming Z and Lavallee M: Contrasting effects of blockade of nitric oxide formation on resistance and conductance coronary vessels in conscious dogs. Cardiovasc Res 31, 555-567 (1996)
25. Kuo L, Chilian W and Davis M: Interaction of pressure- and flow-induced responses in porcine coronary resistance vessels. Am J Physiol 261, H1706-H1715 (1991)
26. Light J, Bellan J, Li Chen I, Longenecker L, Murphy W, Coy D, Kadowitz P and Mcnammara D: Angiopeptin enhances acetylcholine-induced relaxation and inhibits intimal hyperplasia after vascular injury. Am J Physiol 265, H1256-H1274 (1993)
27. Szentivanyi M Jr, Nadasy GL, Dezsi L, Mozes G, Tulassay T and Monos E: Nitric oxide-dependent opposite effects of somatostatin on arterial and venous caliber in situ. Am J Physiol 271, H2238-H2245 (1996)
28. Coy DH, Murphy WA, Raynor K and Reisine T: The new pharmacology of somatostatin and its multiple receptors. J Pediatr Endocrinol 6, 205-209 (1993)
29. Hoyer D, Taylor E, O'Carroll A-M, Patel YC, Schonbrunn A, Reisine T, Bell GI, Kenakin T, Berelowitz M, Epelbaum J, Feniuk W and Humphrey P: Classification and nomemclature of somatostatin receptors. Trends Pharmacol Sci 16, 86-88 (1995)
30. Albers AR, O'Dorisio MS, Balster DA, Caprara M, Gosh P, Chen F, Hoeger C, Rivier J, Wenger GD, O'Dorisio TM and Qualman SJ: Somatostatin receptor gene expression in neuroblastoma. Regul Pept 88, 61-73 (2000)
31. Tornbrandt K, Nobin A and Owman C: Contractile and dilatory action of neuropeptides on isolated human mesenteric blood vessels. Peptides 8, 251-256 (1987)
32. Luu TN, Chester AH, O'Neil GS, Tadjkarimi S and Yacoub MH: Effects of vasoactive neuropeptides on human saphenous vein. Br Heart J 67, 474-477 (1992)
33. Patel YC, Greenwood MT, Wrszynska D, Pannetta R and Srikant CB: All five cloned human somatostatin receptors (hSSTR1-5) are functionally coupled to adenyl cyclase. Biochem Biophys Res Commun 25, 605-612 (1994)
34. Fluori T and Schettini G: Multiple intracellular effectors modulate physiological functions of the cloned somatostatin receptors. J Mol Endocrinol 17, 89-100 (1996)
35. Patel Y and Srikant C: Somatostatin. Trends Endocrinol Metab 8, 398-405 (1997)